Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Matterworks Launches PyxisTM - First AI-Powered, Turn-Key Platform for Identification and Absolute Quantitation from Mass Spectrometry Data


SOMERVILLE, Mass., June 3, 2024 /PRNewswire/ -- Matterworks, Inc., whose foundation AI platform and predictive biology applications accelerate life sciences discovery and development, today announced the release of Pyxis, a new AI-powered platform for untargeted absolute quantitation of analytes.

"AI is revolutionizing how machines interact with data, with many of the initial breakthroughs focused on text and image processing. There is an even greater potential for machines to improve how we analyze complex scientific data," says Jack Geremia, CEO at Matterworks. "We are teaching AI fluency in the raw molecular data that drive life science innovation, from drug discovery to the bioeconomy. We built Pyxis to deliver new biological insight and discovery potential from routine molecular data."

"We've worked extensively with collaborators in the drug development, synthetic biology, and microbiome markets," added Jennifer M. Campbell, CSO at Matterworks. "Understanding their challenges has enabled us to deliver Pyxis to vastly improve both the utility of their MS data and overall efficiency for the analysis of small molecules."

Rapid determination of endogenous metabolite concentrations in biological systems is of unquestionable scientific value across many applications. Pyxis standardizes the entire process of untargeted analyte quantitation. It eliminates the need for per-analyte calibration, peak selection, integration, and manual data analysis. Pyxis enables the direct transformation of uninterpreted, raw LC-MS data to a biologically actionable list of the identities and concentrations of detected metabolites.

"The rapid progress Matterworks has shown in creating an AI model for LC-MS data is truly impressive," commented Eric Carlson, President of Protein Metrics, LLC. "LC-MS data is notoriously complex and yet provides an unparalleled combination of identification and quantification. Pyxis is already making these data available and actionable to scientists."

Pyxis is available today for existing users of high-resolution LC-MS systems. For more information visit https://www.matterworks.ai/pyxis

About Matterworks:

Matterworks is pioneering advances in AI that reveal insights otherwise hidden within the immense complexity of biological data. Our Large Spectral Model (LSM) platform is reinventing the analysis and interpretation of omic measurements. To learn more, visit https://www.matterworks.ai.

SOURCE Matterworks


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: